Philip Morris
Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
Fields
- Author
- Morgan, P.
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Characteristic
- EXTR, EXTRA
- MARG, MARGINALIA
- Named Person
- Svendsen
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Author (Organization)
- Am J Epidemiol
- Site
- R529
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- nhc02a00
Document Images
226
Per iod
Age
LETTERS TO ~ THE EDITOR
_\!f
JI' \ .It~ 5l~
2y! ~' 21,
21, \ 21, 2p
N
Coh
FIGrRE 1; Rates for the non-linear age model. h#l-
culated'in the same way as inTigure 3 ofOsmond artd
Gardner (21.
models onlv "work" as a result of aggregation and
making assumptions of constancy of effect within an
intenal!,
At present we see two avenues for investigators
who wish to trvto estimate the separate linear effec
ofage. period, and cohort: 1)~use a twowactable
d
impose a linear constraint, ignoring the overla ing
of.eohorts: and'21 use the individualI records ap roaeh.
whichidoes not have the problem of overla ,ing co
horts. This approach will reqwire a cor tion for
potential bias brought about by the a mmetry in
forcing the continuous data into a t~ way table.
Brown and Conelly (personal comm ication, 1988)
have informed us of some very int esting work they
are doing in this area.
Finally, in our published ex , mple on the use of
individuallrecords in, the anal 'is of lung cancer and
laryngeal cancer incidence i cotland (31, the cohort
effect is approximately qu ratic and the time effect
small but non-linear. Su effects cannot be induced
by assuming a monoto 'c increasing age effect alone.
REFERENCES.
1. Tango T. Re: "Statistical modelling ofllung cancer
andleryngeal cancer incidence in Scotland, 1960-
1979." Am J Epidemiol 1988;128:67 -8.
2. Osmond C. Gardner MJ. Age, per ^ and cohort
models: non-overlapping eohorta on'c resolve the
identification problem. Am J E' tdemiol 1989:129:
31-5.
3. Boyle P, Rohertson C. Sg4istical modelling of
lung cancer and laryngelA cancer incidence in
Scotland, 1960-1979. A)fi J Epidemiol' 1987;125:
731-44.
4. Osmond C; Gardnej/MJ. Age. period and cohort
models applied toy4ncer mortality rates. Stat Med
1982:1:245-59.
5. Clayton D, Sc fflers E. Models for temporal var-
ihtion in c cer rates: age-periodi egecohort
models. S Med 1987;6:449-67.
6. Fienber E. Mason WM. Identification and es-
timati of age-period-cohort ine the analysis of
discr e and archival data. In: Schuessler KF, ed.
ological'methodologv. San Francisco:,Jossey-
ss, 1978:,
i,/becarli.A; La Vecchia C. Age, period and cohort
smodels: review of knowledge and implementation
~c GLIM~ Revista di Statistica Applicata 1987;
2W9+-410!
8. Holfprd TR. The estimation of age, period and
eohot~ effects for vital rates.. Biometrics 1983;
39;3 S 1 `4.
~
Petet,Boyle
Unit d/.,Anafytical Epidemiology
InternttYional'Agency for Research on Cancer
15a'rour~Alberd- Thomas
F-69372 [,~~omCedez 08
France
Chris Rbbert~qn
department o~fathematics.
Unitersit-v o/ Strathclvde
LiLingstone Toue
26 ~R~ichmond'Stre
Glasgou Gl 1 XH
United Kingdom
AtM,
1 -A- I Ll )
Jo-_.. ~4I'`)
VRE: "EFFECTS OF PASSIVE SMOKING IN THE MULTIPLE RISK FACTOR ~ Zi 6 -7
INTERVENTION TRIAL"
Some of the health effects of'passive smoking may
be smallj and are best investigated in large cohort
studies of persons exposed over a long period; It is
unfortunate that the analysis by Svendsen et al! (1):of
the unique data gathered in the course ofthe Multiple
Risk Factor Intervention Triall (MRFIT) study is
flawed, and may introduce confusion about the role of
passive smoking as a risk factor in cardiovascular
disease. and does not allow the investigators to fully
explore the potential, of passive smoking as a risk
factor in other conditions.
The Svendsen paper repeatedly tests the statistical
significance of the difference between the same pro-
portionlsl. For example, table 7, shows that of the
16a00 never smokers13 men died from coronary, heart
disease and 30 from any cause, and that there were 69
fatal or nonfatal coronary heart disease avents. Each
group is examined for significant difference in propor-
tions according to the wife's smoking status as if it
were independent of the two other groups; in fact, the
coronary hearu disease death group is a subset of the
two other groups, and its contribution to the calcula-
tiomof relative risk is,thus taken into account three
times in this table. The correct analvsis would have
compared 'death from other,causes- and~ "'nonfatal'.
coronary hearu disease events" with "death fivm ~cor-
onary heart disease".
The misuse of statistics is compounded in table 9
when the 2.222 ex-smokers are added to the 1,400
never smokers /this is my, assumption: no n's are

LE7TERS TO: THE EDITOR' 227'
I
given). ln this, analysisthe 13 coronary heart disease
deaths in the never smokers are again included and
the proportions to which they contribute are tested
for statistical significance three more times. The ap,
propriate analysis would have examined only the 2.222
ex-smokers in the same terms, as suggested for
table 7.
The reader who is interested in outcomes other
than coronary hean disease death is forced: to use
guesswork to subtract this effect from the other data
in the tables. For example, even though we are not
told the numbers of inen in table 9, the much lower p
value for "death from any cause" than in table 7
suggests that this difference is due to the contribution
of the ersmokers. Had these been analyzed sepa-
rately, the difference in risk of "death from any cause"
between the exposed and' nonexposed ex-smokers
would probably have been even more markedl This
would have suggested that the men who stopped smok>
ing were especially susceptible to second-hand'tobacco
smoke. A presentation of the data that did not lump
INTERVENTION TRIAL' /1-cl C+ )
and overlap the subsets of Interest would have made
such speculatiortunnecessary:
The studv by Svendsen et all is presented as an
exploration without hypothesis. This "blurred" anak >
sis could have been avoided if this report had set out
to investigate an explicit hypothesis that specified the
target group and the expected endpoint. ParadoxicallY,
focussing in on a specific research question and follbw
ing the method' appropriate to address that question
often allows the researchers to isolateand investigate
secondary or unexpected results more accurately.
REr.ERENCE
1. Svendsen KH. Ku11erLH, Martin d1.1: eu.l. Effectc ofpasst.e smkinR in.the Atuh,pk.Risk.Fanor
1merventwn
Trtal. Am J Epidemiol ]96-.;126:583-95.
Peter Morgan
11&Mif1 Srreet
L.onark, Ontario
Canodo~XUG7J;U
,/RE: 'EFFECTS OF PASSIVE SMOKING IN THE MULTIPLE RISK FACTOR Aw ~!e'lu
Sven?ken et all (l):anal>ze data from the Multiple
Risk FactK Intervention Trial (MRFITI stud, and
report the relative risks of various endpoint events for
men who never oked in relation to spousal smoking..
They assert that eir data provide "further evidence
of a potential serio health risk for a large segment
of the nonsmoking po lation" (1, p. 792). This con-
clusion does not appear vo be supported by the dat.a
presented..
For morbidity and morsali! , the relative risks are
not statistically signifieant, exc t for the "all deaths"
category for the group combining ever smoked" and
"ex-amoker" males. Since the relatt risk for "coro-
nary heart disease deaths" was not st ificantly ele-
vated for that group, the increased rela 've risk for
"all deaths" requires some explanation befo the sta-
tistics can be assumed to indicate a meanin ul in-
crease in health risk related to spousal smoking.
While the statistics alone raise serious doubtabo
should not be disregarded, nor can statistical adjust-
ments be mad'e to eliminate their possible roles. Thus,
while the MRFIT study was well designed to assess
the effect of various interventions according to se-
lected risk factors, it does not appear to have been
designed to assess the environmental tobacco smoke
exposure as a coronarv heart disease risk factor.
Svendsem en al. observe that men whose wives
smoked' had 'significanti? lower levels of pulmonarc
function at baseline" (1, p. 78fi). The authors fail
however, to note and to interpret the data in table 6,
which shows FE\, levels for men whose wt\ es smoked
20+ cigarettes/,dae were markedl. hiFher than those
of men whose wives smoked 1-19cigarettes(daY, both
at baseline and4veraged over all visits. With such a
notable reversaP of the dose-response relbtion, which
must be demonstrated if causal inferences are to be
supported there seemF to be little basis,for suggesunp
the possibility of ant relation betMeen pulmonan
function and spousal smoking from this studl.
the conclusion of increased heal'th,riskfor nonsmokers
exposed to environmental tobacco smoke based' on
spousal smoking, questions also need to be raised
about the quality of the evidence on which the assess-
ments are based, notably the nonhomogeneity between
the groups based'on spousal'smoking classification.
The lack of homogeneity was implicit when adjust-
ments were made for differences in some coronary
heart disease riskiactors, e.g-, age, weight. blood pres-
sure, and alcohol consumption, but there is no indi
cation that the adjustment includ'ed'consideration of
the additive effect of multiple risk factors, as has been,
demonstrated imnumerous other studies, notably, the
Framingham Heart Study: There is no indication that
other coronary heart disease risk factors, e.g., family
history and exercise, were considered or adjusted for,
Differences in forced expiratory volume in one second
(FE\',)',among the groups were also cited. The numer-
ous confuunding coronary heart disease risk facwrs
The weakness of the evidence thus raisec imponant
q stionsabout the conclusion that "pa~site smoking
is a ciatrd with an increase in morbidit\ and mor
tality ong nonsmokers- (1, p. 791). There iF cer-
tainiv , n convincing demonstration that spousal
smoking co titutes a "potential serious health risk-
for any segme of the nonsmoking populanon
RErY.RENtE
1. Gaendrn KH. Kultrr t,.H, \lrmn \t.l, et al Efiens nf
pasnv smuk'tnc in the T~htnlh H~<1 Faci r amenrntmn
Triall Am .l Apidem,nl I9n. L6 7ti+'-Ni.
an \V katzenstein,
lin cn..tPin Aa.uc~ares
51 R ku uod Lritr
Larzh ni. NY ]053F
